Relative risk of tuberculosis in patients with rheumatic diseases managed with anti-tumour necrosis factor-alpha therapy: A nationwide cohort study.

Volkan AydinAhmet AkiciFatma IsliMesil AksoyMehtap AydinHakki Gursoz

Published in: Journal of clinical pharmacy and therapeutics (2019)

This study is the first prescription-based nationwide study to suggest an elevated RR of TB in a comparably younger population with a broad spectrum of RDs managed with any approved anti-TNF-α drug in Turkey.

Keyphrases

mycobacterium tuberculosis
rheumatoid arthritis
pulmonary tuberculosis
adverse drug
stem cells
emergency department
mesenchymal stem cells
hepatitis c virus
drug induced
human immunodeficiency virus
drug administration
hiv infected
antiretroviral therapy